Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 29, 2010
Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivoMaple M Fung, Rany M Salem, Parag Mehtani, et al.
Kidney International|August 14, 2009
Dopamine D1 receptor (DRD1) genetic polymorphism: pleiotropic effects on heritable renal traitsMaple M Fung, Brinda K Rana, Chih-Min Tang, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Peptide YY (PYY) gene polymorphisms in the 3'-untranslated and proximal promoter regions regulate cellular gene expression and PYY secretion and metabolic syndrome traits in vivoPei-An Betty Shih, Lei Wang, Stephane Chiron, et al.
Kidney International|January 25, 2013
Common genetic variants of the human uromodulin gene regulate transcription and predict plasma uric acid levelsJia Han, Ying Liu, Fangwen Rao, et al.
BMC Nephrology|June 18, 2011
Renal kallikrein excretion and epigenetics in human acute kidney injury: expression, mechanisms and consequencesSun Woo Kang, Pei-An Betty Shih, Roy O Mathew, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 12, 2009
Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosisMaple M Fung, Yuqing Chen, Michael S Lipkowitz, et al.
American Journal of Human Genetics|January 24, 2004
Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiologyGen Wen, Sushil K Mahata, Peter Cadman, et al.
Pageof 7